203 related articles for article (PubMed ID: 7384207)
1. "Ethical" drugs.
Rivin AU
Pharos Alpha Omega Alpha Honor Med Soc; 1980; 43(2):9-10. PubMed ID: 7384207
[No Abstract] [Full Text] [Related]
2. The Food and Drug Administration's regulation of drug labeling, advertising, and promotion: looking back and looking ahead.
Hayes TA
Clin Pharmacol Ther; 1998 Jun; 63(6):607-16. PubMed ID: 9663174
[No Abstract] [Full Text] [Related]
3. [On ethical issues of pharmaceutical communication. National Association of Hungarian Pharmaceutical Manufacturers and Wholesalers].
Kata M; Sánta Z
Orv Hetil; 1994 Oct; 135(42):2343-7. PubMed ID: 7970650
[No Abstract] [Full Text] [Related]
4. Drug advertising.
Med J Aust; 1987 Jun; 146(12):660-1. PubMed ID: 3626920
[No Abstract] [Full Text] [Related]
5. Rules of conduct and the pharmaceutical industry.
Collier J
Lancet; 1984 Feb; 1(8374):453. PubMed ID: 6142179
[No Abstract] [Full Text] [Related]
6. Drug promotion: stealth, wealth, and safety.
Lancet; 1993 Jun; 341(8859):1507-8. PubMed ID: 8099382
[No Abstract] [Full Text] [Related]
7. FDA tells drug and device makers to give balanced picture of risks in ads, labels.
Kuehn BM
JAMA; 2009 Jun; 301(24):2541. PubMed ID: 19549965
[No Abstract] [Full Text] [Related]
8. Code of fair practices in the promotion of drug products.
Md State Med J; 1967 Dec; 16(12):139-40. PubMed ID: 6079133
[No Abstract] [Full Text] [Related]
9. Drug ads: how much is hype?
Johns Hopkins Med Lett Health After 50; 2001 Nov; 13(9):1-2. PubMed ID: 11682901
[No Abstract] [Full Text] [Related]
10. Drug marketing in the Third World: beneath the cosmetic reforms.
Greenhalgh T
Lancet; 1986 Jun; 1(8493):1318-20. PubMed ID: 2872442
[No Abstract] [Full Text] [Related]
11. Ethical code of the pharmaceutical industry in Slovakia. (Excerpts).
Med Etika Bioet; 2004; 11(3-4):11-22. PubMed ID: 16294449
[No Abstract] [Full Text] [Related]
12. [Critical reflections on the concept "drug advertising" regarding the marketing of the drug Ponderal (fenfluramine)].
Schjott F
Ugeskr Laeger; 1973 Sep; 135(36):1958-61. PubMed ID: 4774003
[No Abstract] [Full Text] [Related]
13. The dangers of self-dosing.
Schultz S
US News World Rep; 1998 Jul; 125(2):58. PubMed ID: 10181369
[No Abstract] [Full Text] [Related]
14. [Can physicians rely upon the drug information?].
Hansson O
Nord Med; 1976 Jun; 91(6-7-1):193. PubMed ID: 934796
[No Abstract] [Full Text] [Related]
15. [Letter: The Mestoranum affair].
Mikkelsen S; Gregersen P
Ugeskr Laeger; 1973 Sep; 135(36):1937-9. PubMed ID: 4774001
[No Abstract] [Full Text] [Related]
16. Drug advertising.
Moulds RF; Wing LM
Med J Aust; 1989 Apr; 150(7):410-1. PubMed ID: 2716670
[No Abstract] [Full Text] [Related]
17. Promotional literature: how do we critically appraise?
Shetty VV; Karve AV
J Postgrad Med; 2008; 54(3):217-21. PubMed ID: 18626173
[TBL] [Abstract][Full Text] [Related]
18. Rules of conduct and the pharmaceutical industry.
Cox P
Lancet; 1984 Mar; 1(8375):517. PubMed ID: 6142245
[No Abstract] [Full Text] [Related]
19. Peddling drugs to docs.
Heussner RC
Minn Med; 1994 Jun; 77(6):24-31. PubMed ID: 8041331
[No Abstract] [Full Text] [Related]
20. [Pharmaceutic promotion and publicity: quo vadis?].
Castillo Pérez P
Med Clin (Barc); 1992 Sep; 99(8):305-9. PubMed ID: 1453825
[No Abstract] [Full Text] [Related]
[Next] [New Search]
